Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk
Key result
Intra-abdominal adiposity and fat deposition in visceral adipose tissue or the liver signal cardiometabolic risk well beyond the amount of fat itself.
Population
Subjects with obesity and/or diabetes
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May inform refined cardiometabolic risk stratification beyond BMI; leaves open whether targeting visceral or hepatic fat improves outcomes.
Structured PICO
P
Population
Subjects with obesity and/or diabetes
Fat deposition in visceral adipose tissue and the liver signals cardiometabolic risk beyond the absolute amount of fat, despite VAT being inherently more insulin-sensitive than subcutaneous fat.
Cite This Study
Ferrannini et al. (2008) conducted a review in obesity and/or diabetes. Intra-abdominal adiposity was evaluated. Intra-abdominal adiposity and fat deposition in visceral adipose tissue or the liver signal cardiometabolic risk well beyond the amount of fat itself.